July 9, 2024
Mary Ann Carlisle, COO of ELMCRx Solutions, discusses the increasing necessity for alternative funding solutions in prescription drug markets. Authored by Bruce Shutan, the article explores innovative strategies such as patient assistance programs (PAPs) and federal subsidies designed to manage escalating drug costs, highlighting ELMCRx’s commitment to advocating for cost-effective healthcare solutions.
